Modeling COVID|19 vaccine booster|elicited antibody response and ...

Modeling COVID-19 vaccine booster-elicited antibody response and ...

The 3-dose COVID-19 vaccine (booster vaccination) has been offered worldwide. As booster vaccinations continue, it is important to ...

Modeling and predicting individual variation in COVID-19 vaccine ...

Using the individually reconstructed time courses of the vaccine-elicited antibody response based on mathematical modeling, we first identified basic ...

Modeling COVID-19 vaccine booster-elicited antibody response and ...

The trajectories of anti-RBD declines were statistically significantly lower for risk factors of severe COVID-19 and the absence of vaccination ...

Modeling and predicting individual variation in COVID-19 vaccine ...

Modeling and predicting individual variation in COVID-19 vaccine-elicited antibody response in the general population

Longitudinal antibody dynamics after COVID-19 vaccine boosters ...

We modeled temporal declines in antibody levels after COVID-19 vaccine boosters according to prior infection status and booster doses.

SARS-CoV-2-infection- and vaccine-induced antibody responses ...

We next compared antibody kinetics after the first booster immunization to those mounted after the primary vaccination (Figure 3C). In the model, peak antibody ...

SARS-CoV-2 booster vaccine dose significantly extends humoral ...

prophylactic measure to reduce COVID-19 disease pathogenesis. Quantifying the kinetics of the secondary immune response from subsequent ...

Modeling of anti-spike IgG and neutralizing antibody waning after ...

Booster vaccinations are assumed to maintain the antibody level longer. Abstract. At present, mRNA-based vaccines against severe acute ...

A modeling-based approach to optimize COVID-19 vaccine dosing ...

Their model considers an individual's immune response to the initial vaccination, the timing of the booster dose, and the level of immune ...

Mechanistic modeling projections of antibody persistence after ...

S (5 × 1010 vp) in reducing the risk of COVID-19 from 74.8% at 1 month to 59.4% at 5 months post-vaccination, supporting the use of a booster ...

Neutralizing antibody responses elicited by SARS-CoV-2 mRNA ...

The durability of the nAb response is influenced by prior COVID-19 infection and mRNA vaccine type. COVID-19 status was determined by anti–N protein ELISA.

Antibody Response to COVID-19 Booster Vaccination in Healthcare ...

In the first model the fixed factors were the interaction between time (pre-/post-booster) and the history of prior SARS-CoV-2 infection. The subsequent models ...

A Bivalent Omicron-Containing Booster Vaccine against Covid-19

4/5), and the mRNA-1273.214 booster also elicited higher binding antibody responses against multiple other variants (alpha, beta, gamma, and ...

Long-Term Data Reveals SARS-CoV-2 Infection and Vaccine ...

“This study adds an essential piece of data to understand the intricate immune response elicited by SARS-CoV-2 infection and COVID-19 ...

Modeling COVID-19 vaccine-induced immunological memory ... - arXiv

... vaccine-induced immune response ... memory, a third dose of vaccine (booster shot) can induce a significant increase in neutralizing antibody levels.

Booster Dose Vaccination and Dynamics of COVID-19 Pandemic in ...

Methods: A mathematical model with seven compartments was used to determine the basic and effective reproduction numbers and the proportion of infected people ...

Clinical Guidance for COVID-19 Vaccination - CDC

People ages 65 years and older, vaccinated under the routine schedule, are recommended to receive 2 doses of any 2024–2025 COVID-19 vaccine ( ...

Statement on the antigen composition of COVID-19 vaccines

... immune protection elicited by infection and/or vaccination. Data on the immune response specific for XBB.1 descendent lineages are largely ...

The durability of natural infection and vaccine-induced immunity ...

Peak antibody levels elicited by messenger RNA (mRNA) vaccines mRNA-1273 and BNT1262b2 exceeded that of natural infection and are expected to typically yield ...

a pooled analysis of four randomised trials - The Lancet

An exploratory analysis modelling the change in vaccine efficacy ... vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.